AstraZeneca’s Asthma Drug Shows Positive Results – Wall Street Journal


Wall Street Journal

AstraZeneca's Asthma Drug Shows Positive Results
Wall Street Journal
Bing Yao, head of respiratory medicine at AstraZeneca's MedImmune unit, said benralizumab acted directly on the cells that are thought to cause attacks in patients with severe asthma. He said the Glaxo and Teva drugs, by contrast, act indirectly by
AstraZeneca set to go head to head against GSK with asthma drugFinancial Times
AstraZeneca asthma drug hits goal, to enter competitive marketReuters
AstraZeneca's asthma biologic hits PhIII target, but still behind rivalsFierceBiotech
The Guardian –Philadelphia Business Journal –MarketWatch
all 31 news articles »

View full post on asthma – Google News

Leave a Reply

Your email address will not be published. Required fields are marked *